Skip to main content
. 2023 Jan-Feb;38(1):96–103. doi: 10.21470/1678-9741-2021-0278

Table 1.

Demographic characteristics of the study populations.

CABG
AF+ AF- P-value
Variables (n=80) (n=312)
Age (years) 59 (52.5-62) 53 (47-62) 0.003
Male gender (n, %) 57 (71.2%) 245 (78.5%) 0.152
Diabetes mellitus (n, %) 31 (38.7%) 104 (33.3%) 0.363
Hypertension (n, %) 52 (65%) 153 (49%) 0.011
Dyslipidemia (n, %) 12 (15%) 33 (10.5%) 0.268
COPD (n, %) 6 (7.5%) 28 (8.9%) 0.676
Smoking (n, %) 24 (30%) 98 (31.4%) 0.808
BMI (kg/m2) 27.4±5.2 28.1±4.6 0.261
Systolic blood pressure (mmHg) 123.8±15.1 122.6±12.4 0.493
Diastolic blood pressure (mmHg) 76.3±10.4 75.2±7.7 0.295
LVEF (%) 50.4±11.5 58.1±9.7 < 0.001
Left atrium (mm) 3.8 ±0.4 3.7 ±0.5 0.312
Previous medications, n (%)
β-blocker 71 285 0.473
Angiotensin-aldosterone antagonists 62 260 0.224
Statin 76 296 0.963
Operative and postoperative parameters
EuroSCORE II 4.78±0.89 4.56±0,9 0.097
Bypass time (min) 94.8±5.8 96±8.7 0.391
Cross-clamping time (min) 55.5±4.3 56.1±3.5 0.224
Number of bypass grafts 2.9±1.5 2.6±1.3 0.284
Duration of the hospitalization at the intensive care unit (days) 3.08±0.5 3.02±0.7 0.505
Extubation time (hours) 16.4±3.3 16.0±3.6 0.321
Intraoperative mortality (n, %) - - -
In-hospital mortality (n, %) 3 9 0.689

AF=atrial fibrillation; BMI=body mass index; CABG=coronary artery bypass grafting; COPD=chronic obstructive pulmonary disease; EuroSCORE=European System for Cardiac Operative Risk Evaluation; LVEF=left ventricular ejection fraction